PCHF London course

Module 3: Treatment and Follow-up of Heart Failure (20 CME Credits) (PCHF03)


Description
This course contains video recordings of the live lectures from the Postgraduate Course in Heart Failure (PCHF) London 2019-2020.
This module focuses on HF with reduced ejection fraction (HFrEF) and its pathophysiology. Role of the renin angiotensin system, the sympathetic nervous system and related treatment targets: ACE-inhibitors, AT2-antagonists, ARNIs, betablockers, If-channel blockers, mineralocorticoid receptor antagonists, diuretics and digitalis. Pathophysiology of renal injury and the cardiorenal syndrome.
Arrhythmias in HF, including atrial fibrillation and ventricular tachycardias, guidelines and indications for cardiac resynchronisation therapy (CRT).
How to read and interpret randomised controlled trials, device trials and registry-based trails in HF. The patient journey in HF.

The successful completion of this module awards 20 CME Credits (ECMEC®s).

Content
  • Learning Objectives
  • Course overview (Faculty, Structure, Assessment, Certificate)
  • Session 1 – Treatment of HF: general approach (2.5 ECMEC®s)
  • Diagnosis & treatment of HF: the guidelines basics | P. Ponikowski
  • Modulating the renin angiotensin system | L. Lund
  • Blocking the sympathetic nervous system | T.F. Lüscher
  • Heart rate reduction: IF-channel inhibition | M. Cowie
  • List of Publications - Session 1
  • Quiz Session 1
  • Session 2 – Renal Injury and HF / Cardiorenal Syndrome (2.5 ECMEC®s)
  • Management of hyperkalemia | P. Ponikowski
  • RAAS inhibition, serum creatinine and prognosis | L. Lund
  • Current and new biomarkers of renal injury | B. Pitt
  • Pathophysiology of cardio-renal interactions | W. Mullens
  • List of Publications - Session 2
  • Quiz Session 2
  • Session 3 – Treatment of HF: the Old and the New (2.5 ECMEC®s)
  • Diuretics in HF: when and how much? | W. Mullens
  • New diuretic approaches | B. Pitt
  • Angiotensin receptor-neprilysin inhibitors and other novel drugs | M. Packer
  • Digitalis in HF: outdated or a must? | J. Cleland
  • List of Publications - Session 3
  • Quiz Session 3
  • Session 4 – Clinical Trials (2.5 ECMEC®s)
  • How to read and interpret RCTs | M. Packer
  • Challenges to design device trials | J. Cleland
  • Registry-based trials in HF | L. Lund
  • Debate on positive or negative clinical trial | all
  • List of Publications - Session 4
  • Quiz Session 4
  • Session 5 - Atrial fibrillation and chronic HF (2.5 ECMEC®s)
  • ESC and new AHA/ACC/HRS Guidelines | D. Kotecha
  • Debate: Catheter ablation is superior to drugs in AF and HF | D. Shah/M. Packer
  • Anticoagulation in HF | P. Verhamme
  • List of Publications - Session 5
  • Quiz Session 5
  • Session 6 - Workshop AF and CRT-D / Arrhythmias in chronic HF (2.5 ECMEC®s)
  • Live in-a-box: AF ablation | S. Haldar
  • Mobile health technologies in AF | D. Kotecha
  • Live in-a-box: CRT-D | R. Sharma
  • Ventricular tachycardias and ventricular fibrillation in HF | D. Shah
  • Arrhythmia management in GUCH patients | S. Ernst
  • List of Publications - Session 6
  • Quiz Session 6
  • Session 7 - CRT on Chronic Heart Failure (2.5 ECMEC®s)
  • Cardiac anatomy and CRT: lessons from the implanter | R. Sharma
  • Current guidelines and indications for CRT and ICD | J. Cleland
  • When switching from CRT-P to CRT-D? | C. Linde
  • Debate: Do patients with cardiomyopathy need an ICD? | C. Linde/L. Kober
  • List of Publications - Session 7
  • Quiz Session 7
  • Session 8 - Challenges in drug development/ patients journey in HF (2.5 ECMEC®s)
  • SGLT2 inhibitors, the new miracle drugs beyond glucose lowering? | M. Packer
  • The road to ARNIS and beyond | P. Ferber
  • Developing drugs for the myocardium: Omecamtiv mecarbil | C. Varin
  • Rehabilitation programmes in chronic HF | R. Taylor
  • How to collaborate with patients to improve outcome | L. Clayton
  • The backside of the coin – the patients experience | N. Hartshorne-Evans
  • List of Publications - Session 8
  • Quiz Session 8
  • Course Evaluation
  • Course Evaluation Questionnaire
Completion rules
  • You must complete the units "Quiz Session 1, Quiz Session 2, Quiz Session 3, Quiz Session 4, Quiz Session 5, Quiz Session 6, Quiz Session 7, Quiz Session 8, Course Evaluation Questionnaire"
  • Leads to a certification with a duration: Forever